FDA approves first-of-its-kind “living drug” for childhood

Product Description

The Food and Drug Administration on Wednesday approved a groundbreaking cancer treatment for childhood leukemia that uses patients' own genetically altered immune cells to fight the disease. It is the first gene therapy to be allowed in the United States - a "historic" approval, the agency said.

FDA Approves First-of-Its-Kind Drug to Delay Type 1 Diabetes

Federal Register :: Authorizations of Emergency Use of Certain Drug and Biological Products During the COVID-19 Pandemic; Availability

FDA approves first-of-its-kind “living drug” for childhood leukemia – The Denver Post

Cipla Recall – Pediatric Associates

FDA approves Eli Lilly-Boehringer's diabetes drugs for children

U.S. Food and Drug Administration

FDA approves first-of-its-kind “living drug” for childhood leukemia – The Denver Post

FDA accepts sBLA for ALTUVIIIO in children with hemophilia A

NDEWS Weekly Briefing, Issue 102